Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL107882, HL107882-S, HL113443, HL118541)
Boehringer Ingelheim (N/A)
Received: 22 February 2019
Accepted: 22 July 2019
First Online: 23 August 2019
Ethics approval and consent to participate
: Weill Cornell Medicine (WCM) Institutional Review Board approved the protocols. Research subjects were evaluated and consented at the Weill Cornell Medical College Clinical Translational and Science Center and the Department of Genetic Medicine Clinical Research Facility.
: Not applicable.
: The authors declare that they have no competing interests.